Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cvitkovic

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Head & Neck|January 1, 1993
Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancerD Gandia, P Wibault, T Guillot, et al.
American Journal of Clinical Oncology|October 1, 1990
Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinomaE Tellez-Bernal, M Belehradek, G Recondo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
Phase I and pharmacological study of an oxaliplatin and carboplatin combination in advanced malignanciesC Mita, E Chatelut, M Bekradda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Severe CPT-11 toxicity in patients with Gilbert's syndrome: two case reportsE Wasserman, A Myara, F Lokiec, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Phase II study of mitozolomide (M & B 39,565) in head and neck cancerP Herait, J P Armand, M Benahmed, et al.
British Journal of Cancer|December 24, 2010
Single agent and combination studies of pralatrexate and molecular correlates of sensitivityM Serova, I Bieche, M-P Sablin, et al.
Cancer|August 15, 1990
A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancerE Tellez-Bernal, G Recondo, T Guillot, et al.
Anti-Cancer Drugs|May 18, 1999
Decreased topotecan platelet toxicity with successive topotecan treatment cycles in advanced ovarian cancer patientsF Goldwasser, X Buthaud, M Gross, et al.
Bulletin Du Cancer|July 1, 1994
[Undifferentiated carcinoma of the nasopharynx: epidemiological, clinical and therapeutic aspects]A Fandi, B Yanes, A Taamma, et al.
Analytical and Quantitative Cytology and Histology|October 1, 1993
Keratins 6, 13 and 19. Differential expression in squamous cell carcinoma of the head and neckJ Klijanienko, A el-Naggar, F De Braud, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Head & Neck|January 1, 1993
Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancerD Gandia, P Wibault, T Guillot, et al.
American Journal of Clinical Oncology|October 1, 1990
Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinomaE Tellez-Bernal, M Belehradek, G Recondo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
Phase I and pharmacological study of an oxaliplatin and carboplatin combination in advanced malignanciesC Mita, E Chatelut, M Bekradda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Severe CPT-11 toxicity in patients with Gilbert's syndrome: two case reportsE Wasserman, A Myara, F Lokiec, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Phase II study of mitozolomide (M & B 39,565) in head and neck cancerP Herait, J P Armand, M Benahmed, et al.
British Journal of Cancer|December 24, 2010
Single agent and combination studies of pralatrexate and molecular correlates of sensitivityM Serova, I Bieche, M-P Sablin, et al.
Cancer|August 15, 1990
A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancerE Tellez-Bernal, G Recondo, T Guillot, et al.
Anti-Cancer Drugs|May 18, 1999
Decreased topotecan platelet toxicity with successive topotecan treatment cycles in advanced ovarian cancer patientsF Goldwasser, X Buthaud, M Gross, et al.
Bulletin Du Cancer|July 1, 1994
[Undifferentiated carcinoma of the nasopharynx: epidemiological, clinical and therapeutic aspects]A Fandi, B Yanes, A Taamma, et al.
Analytical and Quantitative Cytology and Histology|October 1, 1993
Keratins 6, 13 and 19. Differential expression in squamous cell carcinoma of the head and neckJ Klijanienko, A el-Naggar, F De Braud, et al.
Pageof 13